
浏览全部资源
扫码关注微信
1. 南阳市中心医院产二科,南阳,473000
2. 郑州大学基础医学部,郑州,450000
3. 云南省中医医院肿瘤科,昆明,650021
纸质出版日期:2020,
扫 描 看 全 文
瞿小玲, 曾仪, 姚利, 等. hsa-miR-214-5p通过下调PAK4对子宫颈癌HeLa细胞活力和凋亡的调控作用[J]. 重庆医科大学学报, 2020,45(5):627.
Qu Xiaoling, Zeng Yi, Yao Li, et al. Regulatory role of hsa-miR-214-5p on HeLa cells’ viability and apoptosis by down-regulating PAK4[J]. Journal of Chongqing Medical University, 2020,45(5):627.
目的:探究微小RNA-214-5p(micro RNA-214-5p、miR-214-5p)对宫颈癌HeLa细胞生长和凋亡的作用及机制。方法:将细胞分为HeLa组、mimic-scramble组、miR-214 mimic组和miR-214 inhibitor组,用miR-214 mimic和miR-214 inhi-bitor转染细胞,qRT-PCR检测miR-214和p21活化激酶4(P21-activated kinases 4
PAK4)的表达;生物信息学方法预测miR-214-5p与PAK4的关系,荧光素酶报告实验验证miR-214-5p与PAK4的关系;用pcDNA-PAK4(pc-PAK4)、miR-214 mimic和miR-214 inhibitor转染细胞,Western blot检测PAK4的表达;CCK-8检测细胞活力;流式细胞术检测细胞凋亡。结果:miR-214 mimic组miR-214-5p mRNA的表达水平(46.02±5.23)较HeLa组(1.00±0.01)明显升高(LSD-t=31.423,P=0.000),miR-214 mimic组PAK4蛋白的表达水平(0.08±0.04)较HeLa组(0.26±0.05)明显降低(LSD-t=4.296,P=0.002);miR-214 inhibitor组miR-214-5p mRNA的表达水平(0.41±0.05)较HeLa组(1.00±0.01)明显降低(LSD-t=18.726,P=0.000),miR-214 inhibitor组PAK4蛋白的表达水平(0.58±0.05)较HeLa组(0.26±0.05)明显升高(LSD-t=5.061,P=0.001);miR-214-5p与PAK4可靶向结合。miR-214 mimic组细胞生长速度(3.50±0.45)较HeLa组(5.02±0.35)明显降低(tD=8.644,P=0.000),miR-214 mimic组细胞凋亡率[(11.42±0.71)%]较HeLa组[(2.61±0.63)% ]明显升高(LSD-t=4.032,P=0.003);miR-214 inhibitor组细胞生长速度(5.89±0.32)较HeLa组(5.02±0.35)明显升高(LSD-t=7.863,P=0.000),miR-214 inhibitor组细胞凋亡率[(0.53±0.42)%]较HeLa组[(2.61±0.63)% ]明显降低 (LSD-t=4.221,P=0.002);共转染pc-PAK4能逆转miR-214 mimic对细胞活力和细胞凋亡的调控作用。结论:miR-214-5p能通过靶向下调PAK4抑制宫颈癌HeLa细胞活力并诱导细胞凋亡。
Objective:To investigate the role of micro-RNA-214-5p(miR-241-5p) on the HeLa cells’ cell viability and apoptosis and its mechanism. Methods:HeLa cells were divided into the HeLa group,the mimic-scramble group,the miR-214 mimic group and the miR-214 inhibitor group. The miR-214 mimic and miR-214 inhibitor were used to transfect cells,the qRT-PCR was used to measure expression levels of miR-214 and P21-activated kinases 4(PAK4),the bioinformatic approach was used to predict the rela-tionship of miR-241-5p and PAK4,and the luciferase reporter assay was used to determine their relationship. The pcDNA-PAK4 (pc-PAK4),miR-214 mimic and miR-214 inhibitor were used to transfect HeLa cells,the Western blot was used to determine pro-tein level of PAK4,the CCK-8 assay was used to measure cell viability and the flow cytometry was performed to detect apoptosis. Results:The expression level of miR-214-5p in the miR-214 mimic group(46.02±5.23) was significantly higher than that in the HeLa group (1.00±0.01)(LSD-t=31.423,P=0.000). The expression level of PAK4 in the miR-214 mimic group(0.08±0.04) was significantly lower than that in the HeLa group(0.26±0.05)(LSD-t=4.296,P=0.002). The expression level of miR-214-5p in the miR-214 inhibitor group(0.41±0.05) was significantly lower than that in the HeLa group(1.00±0.01)(LSD-t=18.726,P=0.000). The expression level of PAK4 in the miR-214 inhibitor group(0.58±0.05) was significantly higher than that in the HeLa group of (0.26±0.05)(LSD-t=5.061,P=0.001). The miR-214-5p was able to be targeted-bound with PAK4. The cell growth rate in the miR-214 mimic group(3.50±0.45) was significantly lower than that in the HeLa group(5.02±0.35)(LSD-t=8.644,P=0.000). The apoptosis rate in the miR-214 mimic group[(11.42±0.71)%] was significantly higher than that in the HeLa group[(2.61±0.63)%](LSD-t=4.032,P=0.003). The cell growth rate in the miR-214 inhibitor group(5.89±0.32) was significantly higher than that in the HeLa group(5.02±0.35)(LSD-t=7.863,P=0.000). The apoptosis rate in the miR-214 inhibitor group[(0.53±0.42)%] was significantly lower than that in the HeLa group[(2.61±0.63)%](LSD-t=4.221,P=0.002). Co-transfection of pc-PAK4 was able to reverse the regulation function of miR-214 mimic on cell viability and apoptosis. Conclusion:The miR-214-5p inhibits the viability of HeLa cells and induces their apoptosis by down-regulating PAK4.
宫颈癌miR-214-5pPAK4细胞活力细胞凋亡
cervical cancermicro-RNA-214-5p(miR-214-5p)pcDNA-PAK4(PAK4)cell viabilityapoptosis
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621